Classify the offer before comparing it
Separate an authorized medicine, pharmacy or clinic service, compounded preparation, cosmetic, supplement, and laboratory material. A shared ingredient name does not make those categories interchangeable.
Europe is not one peptide market. This map connects 16 country guides and shows which official record answers the product question, which record answers the seller or supply question, and where a regional assumption must stop. Austria, Belgium, Denmark, and Finland add distinct national product and legal seller checks.
European search results often collapse EU authorization, national market status, pharmacy licensing, online-selling authority, compounding, import, cosmetics, and laboratory materials into one result set. The useful comparison is the verification route in each country, not a region-wide verdict or seller ranking.
Use the same sequence in every country, while allowing the authority, terminology, available fields, and legal route to change.
Separate an authorized medicine, pharmacy or clinic service, compounded preparation, cosmetic, supplement, and laboratory material. A shared ingredient name does not make those categories interchangeable.
Open the country guide and match the exact medicine or product record, including holder, form, strength, authorization, and current market status where the regulator publishes them.
Use the national pharmacy, online-seller, establishment, or professional register linked by the country guide. A regional shipping claim or copied common logo does not replace that record.
These answers preserve the country boundary and point to the source map below. They are not medical or legal advice.
No. Product authorization may involve European and national systems, but market status, pharmacy licensing, online supply, professional authority, import, and enforcement still require the country-specific records linked in this map.
No. A linked common logo can help verify an online medicine seller where that system applies, but it does not by itself establish the authorization, presentation, prescription status, or current market status of the exact product being offered.
No. This regional page compares verification routes, not unlike seller categories. A commercial table would require sourced seller identity, product category, delivery market, exact price, evidence access, and observation date for every included row.
These direct answers resolve the identity and status lane first. Select a destination country before drawing any conclusion about authorization, supply, or a seller.
KPV in Europe is tracked as an FDA-reviewed unapproved peptide identity with preclinical evidence and no identified human administration study. This is not a region-wide authorization, availability, benefit, safety, or supply finding. Choose a destination country and verify its exact product and seller records.
BPC-157 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
TB-500 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
GHK-Cu in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Semax in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Melanotan II in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
MOTS-c in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Tesamorelin in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
AOD-9604 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Ipamorelin in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Selank in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
PT-141 / Bremelanotide in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
CJC-1295 no DAC in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
CJC-1295 DAC in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Retatrutide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Mazdutide has NMPA approvals in China, not a region-wide or worldwide approval for Europe. Verify the destination country's current product and seller records before treating any offer as authorized or available.
Ecnoglutide has NMPA approvals in China, not a region-wide or worldwide approval for Europe. Verify the destination country's current product and seller records before treating any offer as authorized or available.
Enicepatide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Eloralintide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Cagrilintide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Petrelintide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
CagriSema in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
MariTide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Survodutide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
VK2735 in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Pemvidutide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Amycretin / Zenagamtide in Europe refers to an investigational clinical program. It is not an approved product for sale, and seller-labelled material cannot inherit the sponsor's evidence or status.
Tirzepatide in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Orforglipron / Foundayo in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
WEGOVY has an EU marketing authorization, but national prescription, reimbursement, presentation, launch, supply, pharmacy, and seller records still differ across Europe. Choose the destination country and verify its current records.
DSIP / Emideltide in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
IGF-1 LR3 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Kisspeptin-10 / KP-10 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Melanotan I in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
NAD+ in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Sermorelin in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
Thymosin Alpha-1 in Europe is tracked here as a US research-market identity, not a region-wide authorization or supply finding. Choose a destination country and verify the exact product and seller records there.
EGRIFTA WR in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Liraglutide in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
SCENESSE in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
VYLEESI in Europe begins with a US FDA identity reference only. Verify the exact product, presentation, current market status, prescription route, and seller authority in the destination country's records.
Open the first source for the product question and the second source for the seller, pharmacy, establishment, or supply question. Read the full country guide for the exact boundary.
Un guide clair pour distinguer les médicaments autorisés, les circuits officiels et les produits « peptides » vendus en ligne.
A UK market guide built around registered pharmacy access, seller identity, and transparent research-listing evidence.
Ein quellenbasierter Deutschland-Leitfaden, der zugelassene Arzneimittel, erlaubten Versandhandel und Laborangebote getrennt betrachtet, bevor Preis oder Verfügbarkeit verglichen werden.
Una guía para España que separa el estado oficial del medicamento, la farmacia autorizada para venta a distancia y los materiales anunciados solo para investigación antes de comparar ofertas.
Guida italiana all'uso della banca dati AIFA e dell'elenco ministeriale delle farmacie online prima di confrontare un prodotto o un venditore collegato ai peptidi.
Nederlandse gids voor controle in de Geneesmiddeleninformatiebank, de overheidsroute voor online aanbieders, de receptstatus en de identiteit achter een peptideaanbod.
A Switzerland-specific guide to using Swissmedic's authorized-medicine lists, official product information, and internet-medicine guidance before reviewing a peptide offer.
Polski poradnik weryfikacji leków związanych z peptydami w krajowym rejestrze oraz apteki internetowej przez oficjalne logo unijne i Rejestr Aptek.
An Ireland guide to matching peptide-related medicines to HPRA authorization records and checking pharmacies, professionals, and internet suppliers in the live PSI registers.
Um guia de Portugal para verificar medicamentos relacionados com péptidos no Infomed e confirmar se uma farmácia ou site de entrega ao domicílio consta dos registos públicos de licenciamento do INFARMED.
En svensk guide för att kontrollera peptidrelaterade produkter i det nationella läkemedelsregistret och jämföra ett apotek eller en webbsäljare med Läkemedelsverkets tillståndsuppgifter.
Türkiye'de peptit, peptit ilacı, zayıflama ilacı veya araştırma materyali arayanlar için TİTCK ruhsatlı ürün ve ruhsatlı ecza ticarethanesi kayıtlarını birlikte kullanma rehberi. Aynı etken madde adı, Türkçe ürün sayfası veya Türkiye'ye teslimat vaadi tek başına ruhsat ya da yasal tedarik kanıtı değildir.
Ein österreichischer Leitfaden für Suchanfragen zu Peptiden, Peptidarzneimitteln, Gewichtsmanagement-Wirkstoffen und Forschungsmaterialien. Beginne im Arzneispezialitätenregister des BASG und prüfe danach die Apotheke, den Betrieb oder den Versandweg im passenden öffentlichen Register, statt aus einem Wirkstoffnamen oder einer Euro-Preisangabe auf eine zulässige Versorgung zu schließen.
Een Nederlandstalige gids voor zoekopdrachten naar peptiden, peptidegeneesmiddelen, middelen voor gewichtsbeheersing en onderzoeksmaterialen in België. Zoek eerst het exacte geneesmiddel in de databank van het FAGG en controleer daarna de openbare apotheek en haar website via de officiële internetapotheekroute, zonder taal, europrijs of Belgische bezorging als bewijs te behandelen.
En dansk guide til søgninger efter peptider, peptidlægemidler, vægtregulerende stoffer og forskningsmaterialer. Brug Lægemiddelstyrelsens liste over godkendte lægemidler til det præcise produkt, og kontrollér derefter apoteket eller forhandleren i den officielle oversigt over lovligt onlinesalg, før et tilbud sammenlignes.
Suomenkielinen opas peptidien, peptidilääkkeiden, painonhallintalääkkeiden ja tutkimusmateriaalien hakuihin. Tarkista ensin tarkka lääke Fimean lääkehausta tai Kelan lääketietokannasta ja varmista sen jälkeen verkkopalvelun taustalla oleva apteekki Fimean laillisten apteekin verkkopalvelujen luettelosta.
Peptide Local will publish regional commercial comparisons only when every row has a sourced seller category, product status, destination market, comparable price, evidence route, and observation date. The current page compares official verification paths.